Metabolic cardiomyopathy in pediatrics.
Tril VE, Burlutskaya AV, Polischuk LV.
Rev Cardiovasc Med. 2019 Jun 30;20(2):73-80. doi: 10.31083/j.rcm.2019.02.5151.
Inflammation and metabolic cardiomyopathy.
Nishida K, Otsu K.
Cardiovasc Res. 2017 Mar 15;113(4):389-398. doi: 10.1093/cvr/cvx012.
Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy.
Peterson LR, Gropler RJ.
Circ Res. 2020 May 22;126(11):1628-1645. doi: 10.1161/CIRCRESAHA.120.315899. Epub 2020 May 21.
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy.
Chen Z, Jin ZX, Cai J, Li R, Deng KQ, Ji YX, Lei F, Li HP, Lu Z, Li H.
J Mol Med (Berl). 2022 Dec;100(12):1721-1739. doi: 10.1007/s00109-022-02269-1. Epub 2022 Nov 17.
Heart Metabolism in Sepsis-Induced Cardiomyopathy-Unusual Metabolic Dysfunction of the Heart.
Wasyluk W, Nowicka-Stążka P, Zwolak A.
Int J Environ Res Public Health. 2021 Jul 16;18(14):7598. doi: 10.3390/ijerph18147598.
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
Meyers DE, Basha HI, Koenig MK.
Tex Heart Inst J. 2013;40(4):385-94.
Metabolic dysfunction in diabetic cardiomyopathy.
Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE.
Heart Fail Rev. 2014 Jan;19(1):35-48. doi: 10.1007/s10741-013-9377-8.
Autophagy in High-Fat Diet and Streptozotocin-Induced Metabolic Cardiomyopathy: Mechanisms and Therapeutic Implications.
Zhou R, Zhang Z, Li X, Duan Q, Miao Y, Zhang T, Wang M, Li J, Zhang W, Wang L, Jones OD, Xu M, Liu Y, Xu X.
Int J Mol Sci. 2025 Feb 15;26(4):1668. doi: 10.3390/ijms26041668.
Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy.
Kuroshima T, Kawaguchi S, Okada M.
Int J Mol Sci. 2024 Apr 26;25(9):4710. doi: 10.3390/ijms25094710.
Diabetic cardiomyopathy: a metabolic perspective.
Avogaro A, Vigili de Kreutzenberg S, Negut C, Tiengo A, Scognamiglio R.
Am J Cardiol. 2004 Apr 22;93(8A):13A-16A. doi: 10.1016/j.amjcard.2003.11.003.
